ACIP Must Expand Its COVID Prevention Toolkit—Our Children’s Health Depends on It

Commentary

When the Advisory Committee on Immunization Practices (ACIP) convenes on March 18, it will have a rare chance to do something public health advisory bodies struggle to do well: listen to families.

The ACIP meeting agenda covers COVID vaccine injuries, Long COVID, and—critically—ACIP’s own recommendation methodology. That last item may sound bureaucratic, but it’s crucial. How ACIP frames its recommendations determines what pediatricians can prescribe, what insurance will cover, and what choices American parents are ultimately allowed to make for their children.

Right now, that framework is too narrow. And families are paying the price.

Honesty demands acknowledging that some children, particularly adolescent boys, have suffered documented adverse events, acknowledged by the FDA and CDC, following COVID vaccination—including myocarditis and pericarditis.

Parents who witnessed these outcomes in their own children didn’t stop believing in science. They stopped trusting a system that seemed unwilling to fully account for those risks. The consequences of that loss of trust reverberate across all of pediatric medicine. It’s a public health problem that ACIP has the power to help address.

COVID Infection Carries Real Risks Too

Long COVID—formally Post-Acute Sequelae of SARS-CoV-2 (PASC)—affects an estimated 10 percent of people following COVID infection, or tens of millions globally. It is not mild or transient. The persistent viral reservoir that drives Long COVID keeps the immune system in a state of chronic low-grade activation, exhausting infection-fighting cells, disrupting latent viruses, triggering autoimmune responses, and damaging the gut microbiome.

Children are not immune. The potential for long-term effects after COVID infection is real and serious. The goal is not to minimize prevention—it’s to make prevention better, broader, and more honest.

Some children have underlying conditions that make traditional vaccination complicated. Some have personal medical histories that give their pediatricians legitimate cause for concern. And some families—acting in good faith and in consultation with their doctors—are seeking preventive options that account for their child’s unique circumstances.

These families are not fringe voices. They reflect the genuine diversity of American caregiving. Dismissing them, or building a recommendation framework that leaves them with no acceptable options, doesn’t eliminate vaccine hesitancy—it deepens it.

Monoclonal Antibodies Deserve a Seat at the Table

Here is a concrete, evidence-based solution: monoclonal antibodies (mAbs) should be formally recognized by ACIP as a preventive option for COVID in children.

Unlike traditional vaccines, mAbs provide passive immunity—they do not depend on the child’s own immune response to generate protection. That makes them especially valuable for immunocompromised children, infants, and those with contraindications to available vaccines. The science is sound. The need is real. What is missing is ACIP’s explicit, formal recognition that mAbs belong in the pediatric prevention toolkit—recognition that would unlock insurance coverage and broader clinical access.

ACIP’s recommendations are enormously consequential. They shape state immunization schedules, clinical guidance, and insurance coverage nationwide. When those recommendations are built around a methodology that treats traditional vaccines as the only acceptable form of prevention, they inadvertently exclude a significant population of children from the preventive care system altogether.

That is not a pro-vaccine outcome. It is an anti-health one.

The children and caregivers of this country are not asking ACIP to lower its scientific standards. They are asking it to raise its ambition—to build a framework rigorous enough to account for immunological complexity, honest enough to acknowledge known harms, and broad enough to reach every child, regardless of their medical history or their family’s circumstances.

That is not too much to ask. In fact, it is exactly what ACIP was created to do.

Views expressed in this article are the opinions of the author and do not necessarily reflect the views of The Epoch Times.